Skip to main content

Galatek

Galatek provides intelligent automation platforms for life sciences, semiconductor manufacturing, and sustainable energy, combining AI, robotics, and software to streamline complex workflows. Their product portfolio spans liquid handling systems, high-content cell imaging, 3D cell culture workstations, and wafer inspection tools, all designed to improve precision, reproducibility, and throughput. The company reports over 34 million automated sample processing events in life sciences and holds 320 issued patents.

Singapore, Singapore · HQ
263K+ followers
  • Artificial Intelligence
  • AI Agents
  • Data & Analytics
  • Biotechnology
  • Clean Technology
  • Drug Discovery & Therapeutics
  • Energy
  • Hardware
  • Healthcare Technology
  • Industrial Automation
  • Internet of Things
  • New Materials
  • Robotics
  • Semiconductor
  • Software Only
Updated 16 days ago

Funding

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Life science and semiconductor laboratories often rely on manual, labor-intensive processes that introduce variability, limit throughput, and compromise data integrity. Complex workflows such as 3D cell culture, drug screening, and wafer inspection require high precision and reproducibility that are difficult to achieve with manual methods, slowing down research and industrial innovation.

Solution

Galatek designs and delivers intelligent automation solutions that combine AI, robotics, and domain-specific software to streamline scientific and industrial workflows. The company offers tiered automation portfolios—from standalone instruments to fully integrated systems—that can be customized and scaled to meet specific operational needs. Their platforms automate processes such as cell seeding, passaging, media replacement, high-throughput drug addition, and sample analysis, while AI integration improves experimental success rates and data reliability. Galatek's solutions span life sciences, applied chemistry, semiconductors, and sustainable energy, focusing on workflows where precision, reproducibility, and data integrity are critical.

Target Audience

Primary customers are scientists, engineers, and organizations in life sciences, applied chemistry, semiconductors, and sustainable energy sectors that require precision automation for research, drug discovery, and industrial manufacturing workflows.

Features

  • Automated cell culture workstation (G-Viva) for 2D/3D cell culture, including seeding, plating, expansion, passaging, media replacement, and high-throughput drug addition
  • High-content cell imaging system (G-Cell) with high-speed imaging, environmental control, and bright-field, fluorescence, and 3D sample imaging capabilities
  • Integrated platforms for 3D disease model development with AI-enhanced experimental procedures and improved culture success rates
  • Liquid handling systems and smart plate handler series for automated sample processing and multi-step workflow coordination
  • Semiconductor solutions including overlay metrology, wafer advanced inspection, laser dicing, and blade dicing
  • IoT-enabled intelligent transfer robots for cross-regional experimental work and handling of complex samples (high particulate, viscous, flammable, corrosive, toxic)
  • 3D cell culture kits and gels derived from extracellular matrix components with growth factors for regenerative medicine research
This profile is AI-generated and may contain inaccuracies.